Related Experiment Video
Updated: Sep 12, 2025

Isolation and Genome Analysis of Single Virions using 'Single Virus Genomics'
Published on: May 26, 2013
Isolation, characterization, and genomic analysis of a novel phage WSPA with lytic activity against Serratia
Lijuan Li1,2, Kunkun Li1,3, Yu Mi2
1Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy, Dali University, Dali, Yunnan, China.
Abstract:
Serratia marcescens is an established pathogen implicated in hospital-acquired infections and is notorious for its propensity to form biofilms on medical devices, leading to persistent environmental contamination and increased infection risks. Addressing this challenge, our study introduces a novel bacteriophage, Weishan phage (WSPA), isolated from the gut of Periplaneta americana L., exhibiting potent activity against multidrug-resistant strains of S. marcescens. Through comprehensive genomic and proteomic characterization, we classified phage WSPA as a member of the genus Muldoonvirus within the class Caudoviricetes. The WSPA phage has a double-stranded DNA genome of 173,655 base pairs and a GC content of 40.09%. Of the 273 open reading frames identified, 124 encode for proteins with recognized functions in the National Center for Biotechnology Information (NCBI) database, while the remaining 149 are of unknown function. Additionally, we identified six tRNA genes and did not identify any virulence or antibiotic resistance genes. However, given the presence of numerous hypothetical genes with unknown functions, this phage may possess certain therapeutic safety potential, though additional research validation is still required. Comparative genomic analysis revealed that WSPA shares 86.92% sequence identity with the known Serratia phage 4S (MW082584.1). We further assessed the phage's one-step growth characteristics, thermal and pH stability, and determined its host range, which are critical for its application in environmental and clinical settings. Our findings suggest that bacteriophage WSPA could serve as an eco-friendly and effective agent in controlling S. marcescens infections, with promising implications for phage therapy and biocontrol in healthcare environments.IMPORTANCEThis study isolated a novel phage, WSPA, from Periplaneta americana L. gut that specifically targets multidrug-resistant Serratia marcescens. Genomic analysis identified WSPA as a new Muldoonvirus member lacking virulence/resistance genes. With excellent stability and lytic activity, WSPA shows potential for hospital infection control. As the first phage isolated from the cockroach gut, this work expands phage resources and supports medicinal insect phage library development, advancing phage therapy and biocontrol applications.
Insights
A novel bacteriophage, Weishan phage (WSPA), effectively targets multidrug-resistant Serratia marcescens, offering a promising solution for hospital-acquired infections and environmental control.
Area of Science:
- Microbiology
- Virology
- Genomics
Background:
- Serratia marcescens is a significant cause of hospital-acquired infections, often forming biofilms on medical devices.
- Controlling multidrug-resistant strains of S. marcescens is a critical challenge in healthcare settings.
Purpose of the Study:
- To isolate and characterize a novel bacteriophage with potent activity against multidrug-resistant S. marcescens.
- To evaluate the potential of this bacteriophage for therapeutic and biocontrol applications.
Main Methods:
- Isolation of bacteriophage WSPA from the gut of Periplaneta americana L.
- Comprehensive genomic and proteomic characterization of WSPA.
- Assessment of WSPA's host range, stability, and growth characteristics.
Main Results:
- WSPA, classified as a Muldoonvirus, possesses a double-stranded DNA genome and lacks virulence or antibiotic resistance genes.
- Phage WSPA demonstrated potent lytic activity against multidrug-resistant S. marcescens strains.
- WSPA exhibited favorable thermal and pH stability and a defined host range.
Conclusions:
- Bacteriophage WSPA represents a novel and effective agent for controlling S. marcescens infections.
- WSPA holds significant potential for phage therapy and biocontrol in healthcare environments.
- This study expands phage resources and supports the development of phage libraries from medicinal insects.
More Related Videos
13:24An Optimized Enrichment Technique for the Isolation of Arthrobacter Bacteriophage Species from Soil Sample Isolates
Published on: April 9, 2015
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
Related Concept Videos
DNA Bacteriophages
Lytic Cycle of Bacteriophages